Stay updated with breaking news from Eric Soyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PHAXIAM Therapeutics extends its phage portfolio to Klebsiella pneumoniae, a new resistant and aggressive bacterial target Klebsiella pneumoniae is responsible for severe infections and stands out...
18.09.2023 - PRESS RELEASE PHAXIAM Therapeutics announces the completion of its reverse share split Lyon (France) and Cambridge (MA, US), September 18th, 2023 - PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM) (the 'Company'), announces the completion today of ...
ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics Merger approved with large majority by the shareholders of both companiesNew governance structure implementedAmbition to create a global leader in extended phage therapies to ...
ERYTECH announces the approval of the merger with Pherecydes and reports the results of the Combined Shareholder’s Meeting held on June 23, 2023 All resolutions voted with a large majority ac...
ERYTECH announces that Akkadian is continuing its attempt at destabilization with the filing of a new lawsuit Cambridge, MA and Lyon , June 20, 2023 – ERYTECH Pharma announces the filing of... | June 20, 2023